Publication Information

{'id': 'https://openalex.org/W3176722995', 'doi': 'https://doi.org/10.1096/fasebj.23.1_supplement.609.15', 'title': 'Angiotensin II induces upregulation of AT1 receptors via the sequential activation of transcription factors NFkB, Elk‐1 and AP‐1 in Cath.a cells', 'display_name': 'Angiotensin II induces upregulation of AT1 receptors via the sequential activation of transcription factors NFkB, Elk‐1 and AP‐1 in Cath.a cells', 'publication_year': 2009, 'publication_date': '2009-04-01', 'ids': {'openalex': 'https://openalex.org/W3176722995', 'doi': 'https://doi.org/10.1096/fasebj.23.1_supplement.609.15', 'mag': '3176722995'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1096/fasebj.23.1_supplement.609.15', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25293849', 'display_name': 'The FASEB Journal', 'issn_l': '0892-6638', 'issn': ['0892-6638', '1530-6860'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5017626381', 'display_name': 'Amit Mitra', 'orcid': 'https://orcid.org/0000-0003-4046-7070'}, 'institutions': [{'id': 'https://openalex.org/I59130452', 'display_name': 'University of Nebraska Medical Center', 'ror': 'https://ror.org/00thqtb16', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I59130452']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Amit Kumar Mitra', 'raw_affiliation_strings': ['Cellular and Integrative Physiology, Univ. of Nebraska Medical Center, Omaha, NE'], 'affiliations': [{'raw_affiliation_string': 'Cellular and Integrative Physiology, Univ. of Nebraska Medical Center, Omaha, NE', 'institution_ids': ['https://openalex.org/I59130452']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089415637', 'display_name': 'Lie Gao', 'orcid': 'https://orcid.org/0000-0002-7880-7213'}, 'institutions': [{'id': 'https://openalex.org/I59130452', 'display_name': 'University of Nebraska Medical Center', 'ror': 'https://ror.org/00thqtb16', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I59130452']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lie Gao', 'raw_affiliation_strings': ['Cellular and Integrative Physiology, Univ. of Nebraska Medical Center, Omaha, NE'], 'affiliations': [{'raw_affiliation_string': 'Cellular and Integrative Physiology, Univ. of Nebraska Medical Center, Omaha, NE', 'institution_ids': ['https://openalex.org/I59130452']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5030477066', 'display_name': 'Irving H. Zucker', 'orcid': 'https://orcid.org/0000-0003-3636-7720'}, 'institutions': [{'id': 'https://openalex.org/I59130452', 'display_name': 'University of Nebraska Medical Center', 'ror': 'https://ror.org/00thqtb16', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I59130452']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Irving H Zucker', 'raw_affiliation_strings': ['Cellular and Integrative Physiology, Univ. of Nebraska Medical Center, Omaha, NE'], 'affiliations': [{'raw_affiliation_string': 'Cellular and Integrative Physiology, Univ. of Nebraska Medical Center, Omaha, NE', 'institution_ids': ['https://openalex.org/I59130452']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.128, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.36747, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 64, 'max': 71}, 'biblio': {'volume': '23', 'issue': 'S1', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13991', 'display_name': 'Nuclear Receptors and Signaling', 'score': 0.8967, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13991', 'display_name': 'Nuclear Receptors and Signaling', 'score': 0.8967, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11178', 'display_name': 'Receptor Mechanisms and Signaling', 'score': 0.8903, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11503', 'display_name': 'Cytokine Signaling Pathways and Interactions', 'score': 0.8546, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/parthenolide', 'display_name': 'Parthenolide', 'score': 0.89423275}, {'id': 'https://openalex.org/keywords/anisomycin', 'display_name': 'Anisomycin', 'score': 0.47546214}], 'concepts': [{'id': 'https://openalex.org/C127561419', 'wikidata': 'https://www.wikidata.org/wiki/Q224527', 'display_name': 'Downregulation and upregulation', 'level': 3, 'score': 0.9343305}, {'id': 'https://openalex.org/C2780321935', 'wikidata': 'https://www.wikidata.org/wiki/Q2662393', 'display_name': 'Parthenolide', 'level': 3, 'score': 0.89423275}, {'id': 'https://openalex.org/C2908929049', 'wikidata': 'https://www.wikidata.org/wiki/Q65963433', 'display_name': 'Angiotensin II', 'level': 3, 'score': 0.71155363}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.582402}, {'id': 'https://openalex.org/C123915805', 'wikidata': 'https://www.wikidata.org/wiki/Q15332826', 'display_name': 'Angiotensin II receptor type 1', 'level': 4, 'score': 0.5666523}, {'id': 'https://openalex.org/C119056186', 'wikidata': 'https://www.wikidata.org/wiki/Q1431332', 'display_name': 'Gene silencing', 'level': 3, 'score': 0.5320438}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.48107386}, {'id': 'https://openalex.org/C2778073123', 'wikidata': 'https://www.wikidata.org/wiki/Q378498', 'display_name': 'Anisomycin', 'level': 3, 'score': 0.47546214}, {'id': 'https://openalex.org/C2777730290', 'wikidata': 'https://www.wikidata.org/wiki/Q411114', 'display_name': 'NF-κB', 'level': 3, 'score': 0.42516816}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.37105697}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.323555}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.29055372}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.24649599}, {'id': 'https://openalex.org/C184235292', 'wikidata': 'https://www.wikidata.org/wiki/Q421851', 'display_name': 'Kinase', 'level': 2, 'score': 0.18527415}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.078024924}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.07779655}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1096/fasebj.23.1_supplement.609.15', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25293849', 'display_name': 'The FASEB Journal', 'issn_l': '0892-6638', 'issn': ['0892-6638', '1530-6860'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.61}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3148259388', 'https://openalex.org/W3135620012', 'https://openalex.org/W2418445678', 'https://openalex.org/W2158772048', 'https://openalex.org/W2109896298', 'https://openalex.org/W2093949391', 'https://openalex.org/W2090731568', 'https://openalex.org/W2034924769', 'https://openalex.org/W2026743167', 'https://openalex.org/W1991157605'], 'abstract_inverted_index': {'It': [0], 'has': [1], 'been': [2], 'clearly': [3], 'established': [4], 'that': [5], 'increased': [6, 103], 'circulating': [7], 'Angiotensin': [8, 19], 'II': [9, 67, 82, 135], '(Ang': [10], 'II)': [11], 'with': [12, 65], 'concurrent': [13], 'upregulation': [14, 172], 'of': [15, 28, 40, 43, 89, 93, 100, 111, 129, 165], 'brain': [16], 'and': [17, 48, 102, 106, 137, 168], 'peripheral': [18], '1‐receptors': [20], '(AT1R)': [21], 'are': [22, 154], 'important': [23], 'mediators': [24], 'in': [25, 50, 124, 156, 170, 174, 181], 'the': [26, 38, 90, 117, 157, 171], 'pathophysiology': [27], 'heart': [29], 'failure.': [30], 'In': [31], 'this': [32], 'study': [33], 'we': [34], 'aim': [35], 'to': [36, 121, 185], 'determine': [37], 'role': [39, 164], 'sequential': [41], 'activation': [42, 110, 136], 'transcription': [44], 'factors': [45], 'NFκB,': [46, 166], 'AP‐1': [47, 169], 'Elk‐1': [49, 130, 167], 'AT1R': [51, 107, 125], 'upregulation.': [52], 'We': [53], 'used': [54], 'Cath.a': [55, 175], 'cells': [56], 'as': [57, 150], 'our': [58], 'neuronal': [59], 'cell': [60], 'model': [61], 'which': [62], 'was': [63, 75, 85, 96, 113, 131, 138], 'treated': [64], 'Ang': [66, 81, 134], '(100nM)': [68], 'over': [69], 'a': [70, 86, 97, 122, 162], 'time': [71], 'course.': [72], 'Western': [73], 'blotting': [74], 'done': [76], 'for': [77], 'protein': [78, 182], 'expression.': [79, 108, 126], 'Following': [80], 'activation,': [83], 'there': [84], 'temporal': [87], 'increase': [88], 'p65': [91], 'subunit': [92], 'NFkB.': [94], 'There': [95], 'concomitant': [98], 'decrease': [99, 123], 'IκB': [101], 'IκK': [104], 'expression': [105, 128, 183], 'The': [109, 127, 152], 'NFκB': [112, 141], 'blocked': [114], 'by': [115], 'using': [116, 145], 'inhibitor': [118], 'Parthenolide': [119], 'leading': [120], 'upregulated': [132], 'following': [133, 140], 'decreased': [139], 'inhibition.': [142], 'Gene': [143], 'silencing': [144], 'p65‐siRNA': [146], 'had': [147], 'similar': [148], 'effects': [149], 'Parthenolide.': [151], 'data': [153], 'presented': [155], 'table.': [158], 'Our': [159], 'results': [160], 'suggest': [161], 'combined': [163], 'AT‐1R': [173], 'cells.': [176], 'Table': [177], 'showing': [178], 'fold': [179], 'change': [180], 'compared': [184], 'control.': [186, 189], '*p<0.01': [187], 'vs.': [188]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3176722995', 'counts_by_year': [], 'updated_date': '2024-12-16T00:23:55.437605', 'created_date': '2021-07-05'}